INmune Bio (INMB) Short Interest Ratio & Short Volume $8.59 -0.50 (-5.50%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$8.60 +0.01 (+0.06%) As of 02/21/2025 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends INmune Bio Short Interest DataINmune Bio (INMB) has a short interest of 5.51 million shares. This marks a 9.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 16.7, indicating that it would take 16.7 days of the average trading volume of 448,475 shares to cover all short positions.Current Short Interest5,510,000 sharesPrevious Short Interest5,030,000 sharesChange Vs. Previous Month+9.54%Dollar Volume Sold Short$55.98 millionShort Interest Ratio16.7 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares22,170,000 sharesPercentage of Shares Shorted24.85%Today's Trading Volume274,251 sharesAverage Trading Volume448,475 sharesToday's Volume Vs. Average61% Short Selling INmune Bio? Sign up to receive the latest short interest report for INmune Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINMB Short Interest Over TimeINMB Days to Cover Over TimeINMB Percentage of Float Shorted Over Time INmune Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20255,510,000 shares $55.98 million +9.5%N/A16.7 $10.16 1/15/20255,030,000 shares $31.59 million +17.5%N/A17 $6.28 12/31/20244,280,000 shares $19.99 million +7.0%N/A18.6 $4.67 12/15/20244,000,000 shares $19 million +7.8%N/A17.2 $4.75 11/30/20243,710,000 shares $18.74 million +3.9%N/A14.3 $5.05 11/15/20243,570,000 shares $17.69 million +2.6%N/A14.4 $4.96 10/31/20243,480,000 shares $20.36 million +23.0%N/A14 $5.85 10/15/20242,830,000 shares $13.67 million +5.6%N/A12.6 $4.83 9/30/20242,680,000 shares $14.45 million -15.2%N/A12.3 $5.39 9/15/20243,160,000 shares $17.25 million +4.6%N/A14 $5.46 Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 8/31/20243,020,000 shares $19.99 million +8.6%22.5%16.6 $6.62 8/15/20242,780,000 shares $19.10 million +3.0%20.7%15.9 $6.87 7/31/20242,700,000 shares $23.19 million -0.7%20.1%17.1 $8.59 7/15/20242,720,000 shares $25.92 million +27.1%20.3%16.4 $9.53 6/30/20242,140,000 shares $18.87 million +7.5%16.0%12.8 $8.82 6/15/20241,990,000 shares $16.90 million +4.7%14.8%15.4 $8.49 5/31/20241,900,000 shares $17.96 million -1.0%14.2%16.2 $9.45 5/15/20241,920,000 shares $21.81 million +11.0%14.7%16.5 $11.36 4/30/20241,730,000 shares $20.48 million +15.3%13.5%15.3 $11.84 4/15/20241,500,000 shares $14.37 million -2.0%12.7%15.1 $9.58 3/31/20241,530,000 shares $17.98 million +6.3%13.0%17.7 $11.75 3/15/20241,440,000 shares $15.93 million +3.6%12.3%18.7 $11.06 2/29/20241,390,000 shares $16.12 million +18.8%11.9%16 $11.60 2/15/20241,170,000 shares $16.12 million No Change10.0%14.1 $13.78 1/31/20241,170,000 shares $13.96 million +3.5%10.0%16.2 $11.93 1/15/20241,130,000 shares $14.29 million +2.7%9.6%18.3 $12.65 12/31/20231,100,000 shares $12.39 million -3.5%9.4%19.2 $11.26 12/15/20231,140,000 shares $12.16 million -5.0%9.7%22.1 $10.67 11/30/20231,200,000 shares $11.34 million -0.8%11.5%27.1 $9.45 11/15/20231,210,000 shares $8.62 million -0.8%11.6%30.5 $7.12 10/31/20231,220,000 shares $8.89 million -4.7%11.7%32.2 $7.29 10/15/20231,280,000 shares $8.88 million +0.8%14.8%31.7 $6.94 9/30/20231,270,000 shares $8.60 million +13.4%13.1%22.3 $6.77 9/15/20231,120,000 shares $8.89 million -1.8%11.5%19.6 $7.94 8/31/20231,140,000 shares $9.23 million No Change9.7%20.6 $8.10 8/15/20231,140,000 shares $9.30 million No Change9.7%19.5 $8.16 7/31/20231,140,000 shares $9.77 million +3.6%9.7%18.5 $8.57 7/15/20231,100,000 shares $11.99 million No Change9.4%18.1 $10.90 6/30/20231,100,000 shares $9.99 million +4.8%9.4%24 $9.08 6/15/20231,050,000 shares $9.68 million +1.9%9.0%20.5 $9.22Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th. 5/31/20231,030,000 shares $7.81 million No Change8.8%20.3 $7.58 5/15/20231,030,000 shares $8.02 million No Change8.8%21.1 $7.79 4/30/20231,030,000 shares $7.47 million -1.9%8.8%20.2 $7.25 4/15/20231,050,000 shares $9.10 million -0.9%9.0%19 $8.67 3/31/20231,060,000 shares $6.85 million No Change9.1%17.7 $6.46 3/15/20231,060,000 shares $7.22 million -0.9%9.1%19 $6.81 2/28/20231,070,000 shares $10.10 million -0.9%9.2%19.5 $9.44 2/15/20231,080,000 shares $10.52 million No Change9.3%19.8 $9.74 1/31/20231,080,000 shares $9.27 million +9.4%9.3%19.9 $8.58 1/15/2023987,000 shares $8.73 million +4.4%8.5%20.4 $8.84 12/30/2022945,300 shares $5.99 million +3.5%8.1%21.1 $6.34 12/15/2022913,700 shares $6.86 million +2.8%7.8%20.7 $7.51 11/30/2022889,100 shares $6.36 million -2.3%7.6%19.2 $7.15 11/15/2022910,300 shares $7.10 million -3.1%7.8%19.1 $7.80 10/31/2022939,400 shares $7.21 million +2.3%8.1%19.4 $7.67 10/15/2022918,500 shares $5.69 million -0.5%7.9%17.1 $6.20 9/30/2022923,300 shares $5.72 million +3.5%7.9%16.8 $6.20 9/15/2022892,400 shares $7.32 million -9.9%7.7%14 $8.20 8/31/2022989,900 shares $7.99 million +2.2%8.5%15.3 $8.07 8/15/2022968,900 shares $8.88 million -1.1%8.3%9.4 $9.17 7/31/2022979,400 shares $8.79 million -3.0%8.4%8.8 $8.97 7/15/20221,010,000 shares $10.34 million -6.5%8.7%8 $10.24 6/30/20221,080,000 shares $9.55 million -1.8%9.3%8.1 $8.84 6/15/20221,100,000 shares $7.66 million +6.8%9.4%7.9 $6.96 5/31/20221,030,000 shares $7.11 million -20.2%8.8%6.7 $6.90 5/15/20221,290,000 shares $9.15 million +3.2%11.1%9.4 $7.09 4/30/20221,250,000 shares $9.40 million +16.8%10.7%8.9 $7.52 4/15/20221,070,000 shares $8.89 million -9.3%9.2%7.4 $8.31 3/31/20221,180,000 shares $9.94 million +13.5%10.2%8.2 $8.42 3/15/20221,040,000 shares $6.68 million -8.8%8.9%6.4 $6.42 2/28/20221,140,000 shares $10.03 million +7.6%9.8%6.5 $8.80 2/15/20221,060,000 shares $11.33 million -3.6%9.1%6.2 $10.69 1/31/20221,100,000 shares $11.10 million +3.8%9.4%5.3 $10.09 1/15/20221,060,000 shares $9.31 million +1.9%9.1%4.6 $8.78 12/31/20211,040,000 shares $10.61 million +8.5%8.9%4.6 $10.20 12/15/2021958,700 shares $10.49 million -3.9%8.2%3.8 $10.94 11/30/2021997,800 shares $12.82 million -3.1%8.6%3.4 $12.85 11/15/20211,030,000 shares $14.89 million -7.2%8.8%2.6 $14.46 10/29/20211,110,000 shares $20.41 million +8.8%9.5%2.8 $18.39 10/15/20211,020,000 shares $18.99 million -9.7%8.8%2.4 $18.62 9/30/20211,130,000 shares $21.94 million +13.9%9.8%2 $19.42 9/15/2021992,000 shares $17.32 million -4.6%8.6%1.7 $17.46 8/31/20211,040,000 shares $24.67 million -10.3%8.8%1.9 $23.72 8/13/20211,160,000 shares $19.23 million -0.9%9.9%2.7 $16.58 7/30/20211,170,000 shares $17.81 million +14.7%9.9%2.8 $15.22 7/15/20211,020,000 shares $22.54 million +8.0%8.7%3.1 $22.10 6/30/2021944,900 shares $16.60 million -1.5%10.6%3.5 $17.57 6/15/2021958,800 shares $17.27 million -0.3%10.8%5.5 $18.01 5/28/2021961,600 shares $13.04 million +21.6%10.8%6 $13.56 5/14/2021790,700 shares $7.35 million -0.5%8.9%4.4 $9.29Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th. 4/30/2021795,000 shares $9.34 million +38.5%9.7%4.2 $11.75 4/15/2021574,000 shares $6.76 million +5.5%7.0%2.2 $11.77 3/31/2021544,300 shares $6.48 million +10.5%7.3%1.8 $11.91 3/15/2021492,500 shares $7.84 million +35.1%6.6%1.4 $15.92 2/26/2021364,600 shares $5.92 million -18.5%5.5%1.1 $16.25 2/12/2021447,400 shares $8.94 million -7.0%6.7%1.5 $19.99 1/29/2021481,000 shares $9.04 million -11.5%7.2%1.7 $18.80 1/15/2021543,500 shares $13.54 million No Change8.1%2.2 $24.92 9/15/2020373,100 shares $3.90 million +5.4%5.6%0.3 $10.44 8/31/2020354,100 shares $3.72 million +252.3%5.3%0.3 $10.50 8/14/2020100,500 shares $973,845.00 +297.2%1.6%0.1 $9.69 7/31/202025,300 shares $293,986.00 -77.5%0.5%0 $11.62 7/15/2020112,400 shares $1.47 million +282.3%2.4%0.1 $13.05 6/30/202029,400 shares $158,466.00 +297.3%0.8%0.5 $5.39 6/15/20207,400 shares $39,812.00 +48.0%0.2%0.2 $5.38 5/29/20205,000 shares $28,450.00 -85.8%0.1%0.1 $5.69 5/15/202035,100 shares $193,401.00 +80.9%0.9%0.7 $5.51 4/30/202019,400 shares $98,358.00 +743.5%0.5%0.5 $5.07 4/15/20202,300 shares $9,568.00 -64.1%0.1%0.1 $4.16 3/31/20206,400 shares $21,312.00 +106.5%0.2%0.2 $3.33 3/13/20203,100 shares $9,610.00 -74.6%0.1%0 $3.10 2/28/202012,200 shares $53,741.00 -35.8%0.3%0.6 $4.41 INMB Short Interest - Frequently Asked Questions What is INmune Bio's current short interest? Short interest is the volume of INmune Bio shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 5,510,000 shares of INMB short. Learn More on INmune Bio's current short interest. What is a good short interest ratio for INmune Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INMB shares currently have a short interest ratio of 17.0. Learn More on INmune Bio's short interest ratio. Which institutional investors are shorting INmune Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of INmune Bio: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is INmune Bio's short interest increasing or decreasing? INmune Bio saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 5,510,000 shares, an increase of 9.5% from the previous total of 5,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does INmune Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to INmune Bio: Avid Bioservices, Inc. (18.17%), Nuvation Bio Inc. (11.00%), Prothena Co. plc (16.54%), Cronos Group Inc. (1.89%), GH Research PLC (7.79%), Verve Therapeutics, Inc. (21.00%), Mind Medicine (MindMed) Inc. (37.68%), Dianthus Therapeutics, Inc. (30.61%), Anavex Life Sciences Corp. (27.55%), Opthea Limited (0.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short INmune Bio stock? Short selling INMB is an investing strategy that aims to generate trading profit from INmune Bio as its price is falling. INMB shares are trading down $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INmune Bio? A short squeeze for INmune Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INMB, which in turn drives the price of the stock up even further. How often is INmune Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INMB, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies CDMO Short Interest NUVB Short Interest PRTA Short Interest CRON Short Interest GHRS Short Interest VERV Short Interest MNMD Short Interest DNTH Short Interest AVXL Short Interest OPT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INMB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INMB Stock Alerts